Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025

DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in Advanced Therapies Integrates North 2025, taking place on 30 April 2025 at the Usher Institute in Edinburgh. As a recognised leader in expanding access to innovative therapies for complex, chronic and rare diseases, AscellaHealth will be represented by Gillian Molloy, vice president, Market Access, who will serve as a panellist during the session, Strength in Numbers, scheduled from 12:20 - 13:00.

With nearly 20 years of experience across the European and US life sciences sectors, Molloy will bring her deep expertise in strategic innovation and market access to the panel discussion, offering valuable perspectives on the power of collaboration in advanced therapy medicinal product (ATMP) development. Drawing on her extensive transatlantic experience, she will share practical strategies for building effective partnerships and provide real-world insights into overcoming key industry challenges—particularly the regulatory and commercial hurdles that can impede the advancement of transformational ATMPs.

At AscellaHealth, Molloy works closely with pharmaceutical manufacturers and healthcare organisations, delivering consultative strategies that enhance the patient treatment journey, improve clinical outcomes and optimise commercialisation for complex therapies.

In addition to her participation at the Advanced Therapies Integrates North, Molloy and Alexis Moss, director of business development, AscellaHealth, will also be featured as panellists in a series of upcoming virtual roundtable webinars hosted by the Life Science Access Academy this June:

  • Alexis Moss - Homecare: An NHS Update – 20 June 2025. Register here.
  • Gillian Molloy - Gene Therapy: Rhetoric vs Reality – 27 June 2025. Register here.

Moss brings over two decades of experience in the healthcare sector and leads AscellaHealth’s global business development initiatives. She is instrumental in driving cost-effective, patient-centred solutions through strategic partnerships with pharmaceutical manufacturers and healthcare stakeholders.

“These are exciting times for advancing ATMP clinical development and this meeting serves as a pivotal platform for exploring faster, smarter and more efficient development pathways,” says Molloy, who will also play an active role in the November 2025 Advanced Therapies Integrates North event. “Through collaboration and shared expertise, we can navigate the complexities of market access and work together to ensure patients around the world benefit from the full promise of these breakthrough treatments.”

To arrange a 1:1 meeting with AscellaHealth during Advanced Therapies Integrates North 2025, please contact businessdevelopment@ascellahealth.com.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. For more information on our services and solutions, visit www.AscellaHealth.eu or www.AscellaHealth.com.

This press release was published by a CLEAR® Verified individual.


Media:
Caroline Chambers
CPR Communications
cchambers@cpronline.com
201.641.1911 x 21

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.